KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Income from Continuing Operations (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Income from Continuing Operations for 4 consecutive years, with 211694000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Income from Continuing Operations fell 22.31% year-over-year to 211694000.0, compared with a TTM value of 892869000.0 through Dec 2023, up 57.62%, and an annual FY2025 reading of 312763000.0, up 42.83% over the prior year.
  • Income from Continuing Operations was 211694000.0 for Q4 2023 at Ginkgo Bioworks Holdings, up from 302891000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 26465000.0 in Q3 2021 and bottomed at 1738741020.0 in Q4 2021.
  • Average Income from Continuing Operations over 4 years is 360017297.5, with a median of 189142000.0 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations tumbled 2824.17% in 2021, then soared 90.05% in 2022.
  • Year by year, Income from Continuing Operations stood at 59461000.0 in 2020, then crashed by 2824.17% to 1738741020.0 in 2021, then skyrocketed by 90.05% to 173078000.0 in 2022, then decreased by 22.31% to 211694000.0 in 2023.
  • Business Quant data shows Income from Continuing Operations for DNA at 211694000.0 in Q4 2023, 302891000.0 in Q3 2023, and 173315000.0 in Q2 2023.